These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16356248)

  • 1. Antithrombin in sepsis revisited.
    Levi M
    Crit Care; 2005; 9(6):624-5. PubMed ID: 16356248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis.
    Kountchev J; Bijuklic K; Bellmann R; Wiedermann CJ; Joannidis M
    Crit Care; 2005; 9(6):R596-600. PubMed ID: 16280058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis, coagulation, and antithrombin: old lessons and new insights.
    Levi M; Schouten M; van der Poll T
    Semin Thromb Hemost; 2008 Nov; 34(8):742-6. PubMed ID: 19214912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin concentrate use in sepsis-associated disseminated intravascular coagulation: re-evaluation of a 'pendulum effect' drug using a nationwide database.
    Tagami T
    J Thromb Haemost; 2018 Mar; 16(3):458-461. PubMed ID: 29316251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin substitution therapy.
    Schinzel H; Weilemann LS
    Blood Coagul Fibrinolysis; 1998 Nov; 9 Suppl 3():S17-21; discussion S21-2. PubMed ID: 10102495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation.
    Iba T; Nagaoka I; Boulat M
    Thromb Res; 2013 May; 131(5):383-9. PubMed ID: 23566533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T; Kohno Y; Koishi K
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin concentrate use in disseminated intravascular coagulation of sepsis: meta-analyses revisited.
    Wiedermann CJ
    J Thromb Haemost; 2018 Mar; 16(3):455-457. PubMed ID: 29316235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
    de Jonge E; van der Poll T; Kesecioglu J; Levi M
    Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose antithrombin therapy for sepsis.
    Iba T; Kidokoro A
    J Trauma; 2000 Nov; 49(5):979-80. PubMed ID: 11086799
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombin replacement in patients with sepsis and septic shock.
    Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
    Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III in Sepsis. New evidences and open questions.
    Ostermann H
    Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombin therapy of no value in sepsis according to a large clinical trial].
    Gårdlund B
    Lakartidningen; 2002 Mar; 99(13):1456-7, 1460. PubMed ID: 11989356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of protein C concentrate in pediatric patients with sepsis.
    Silvani P; Camporesi A; Licari E; Wolfler A
    Minerva Anestesiol; 2005 Jun; 71(6):373-8. PubMed ID: 15886604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of anticoagulant strategies on activation of inflammation and coagulation.
    Feistritzer C; Wiedermann CJ
    Expert Opin Biol Ther; 2007 Jun; 7(6):855-70. PubMed ID: 17555371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early administration of high-dose antithrombin in severe sepsis: single center results from the KyberSept-trial.
    Eid A; Wiedermann CJ; Kinasewitz GT
    Anesth Analg; 2008 Nov; 107(5):1633-8. PubMed ID: 18931224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin: anti-inflammatory properties and clinical applications.
    Levy JH; Sniecinski RM; Welsby IJ; Levi M
    Thromb Haemost; 2016 Apr; 115(4):712-28. PubMed ID: 26676884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of anorexia nervosa with disseminated intravascular coagulation syndrome.
    Haruta I; Asakawa A; Ogiso K; Amitani H; Amitani M; Tsai M; Hamada S; Inui A
    Int J Eat Disord; 2012 Apr; 45(3):453-5. PubMed ID: 22407868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.